Does IPILIMUMAB Cause Diabetic ketoacidosis? 358 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 358 reports of Diabetic ketoacidosis have been filed in association with IPILIMUMAB (YERVOY). This represents 1.0% of all adverse event reports for IPILIMUMAB.
358
Reports of Diabetic ketoacidosis with IPILIMUMAB
1.0%
of all IPILIMUMAB reports
18
Deaths
275
Hospitalizations
How Dangerous Is Diabetic ketoacidosis From IPILIMUMAB?
Of the 358 reports, 18 (5.0%) resulted in death, 275 (76.8%) required hospitalization, and 105 (29.3%) were considered life-threatening.
Is Diabetic ketoacidosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 358 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Diabetic ketoacidosis?
EMPAGLIFLOZIN (3,644)
CANAGLIFLOZIN (3,413)
DAPAGLIFLOZIN (1,773)
METFORMIN (1,584)
INSULIN ASPART (1,398)
INSULIN LISPRO (924)
INSULIN GLARGINE (776)
NIVOLUMAB (687)
DAPAGLIFLOZIN PROPANEDIOL (547)
PEMBROLIZUMAB (397)
Which IPILIMUMAB Alternatives Have Lower Diabetic ketoacidosis Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN